The effect of inhaled magnesium sulfate in asthma

Comparing the effect of Daolin nebulizer based on normal saline with Daolin based on magnesium sulfate on one-hour prognosis of severe asthma attack

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20251105067885N1

Enrollment

Registered

2025-11-12

Start date

2025-11-01

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. Asthma

Interventions

Intervention 1: Control group: Under treatment with Daolin nebulizer (2.5 cc) + normal saline (2.5 cc) In the first hour of the asthma attack, 3 episodes are repeated every 20 minutes. The above medic

Eligibility

Sex/Gender

All

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: All cases of children aged 2 to 17 years who had presented to the emergency department of Amirkabir Hospital with a severe asthma attack No need for mechanical ventilation at the time of presentation No comorbidities such as chronic pulmonary, cardiovascular, renal, neurological, or other systemic diseases

Exclusion criteria

Exclusion criteria: Need for mechanical ventilation, decreased level of consciousness and intubation during treatment Sensitivity to magnesium

Design outcomes

Primary

Measure	Time frame
Respiratory status. Timepoint: Before the intervention and one hour after it. Method of measurement: Spirometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Bastani

Arak University of Medical Sciences

Dr.bastani81@yahoo.com+98 86 3313 5075

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026